Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06362044
Status:
RECRUITING
Last Update Posted:
2024-04-12
First Post:
2024-04-09
Brief Title:
A Study to Assess Frequency of Undetectable Minimal Residual Disease uMRD in Adult Participants With Chronic Lymphocytic Leukemia CLL Receiving Oral Venetoclax Tablets Intravenously IV Infused Rituximab in Routine Clinical Practice in Japan
Sponsor:
AbbVie
Organization:
AbbVie